Services

Histology

Pharmacology

Medical Device Testing

In Vitro Screening

Animal Model Development

Custom Assay Development

Vivarium Rental

Toxicology

Species

Non-human Primates

Dogs

Mini-pigs / Pigs

Rabbits

Mice

Rats

Sheep

Guinea Pigs

Hamsters

Other Species

Therapeutic Areas

Oncology

Immunology & Inflammation

Neurology / CNS

Cardiovascular

Dermatology & Wound Healing

Metabolism

Gastroenterology

Hepatology

Pulmonology

Infectious Diseases & Sepsis

Musculoskeletal

Nephrology & Urology

Capabilities

GLP / IND-Enabling Studies

Small and Large Animal Housing

Bioanalytical Platforms

About

News

Contact

Career

Request a Quote

Logo
☰
  • Services ⌄
    • Histology
    • Pharmacology
    • Medical Device Testing
    • In Vitro Screening
    • Animal Model Development
    • Custom Assay Development
    • Vivarium Rental
    • Toxicology
  • Species ⌄
    • Non-human Primates
    • Dogs
    • Mini-pigs / Pigs
    • Rabbits
    • Mice
    • Rats
    • Sheep
    • Guinea Pigs
    • Hamsters
    • Other Species
  • Therapeutic Areas ⌄
    • Oncology
    • Immunology & Inflammation
    • Neurology / CNS
    • Cardiovascular
    • Dermatology & Wound Healing
    • Metabolism
    • Gastroenterology
    • Hepatology
    • Pulmonology
    • Infectious Diseases & Sepsis
    • Musculoskeletal
    • Nephrology & Urology
  • Capabilities ⌄
    • GLP / IND-Enabling Studies
    • Small and Large Animal Housing
    • Bioanalytical Platforms
  • About ⌄
    • News
  • Contact ⌄
    • Career
    • Request a Quote

What Device Manufacturers Can Learn From FDA’s Inspection Data

  • Post author:Sam
  • Post published:August 4, 2017
  • Post category:The GMP Letter

Medical device quality managers that don’t want to wind up a statistic in a future FDA report on quality deviations should dig deeply into the agency’s recently released report on…

Continue ReadingWhat Device Manufacturers Can Learn From FDA’s Inspection Data

Brazil Adds Ireland as MDSAP Accredited Quality Auditor

  • Post author:Sam
  • Post published:August 4, 2017
  • Post category:The GMP Letter

Brazil’s National Surveillance Agency has added Ireland’s standards authority to its list of accredited organizations to perform quality management system audits under the Medical Device Single Audit Program. Source: The…

Continue ReadingBrazil Adds Ireland as MDSAP Accredited Quality Auditor

FDA Exempts 1,003 Class II Devices From 510(k) Regs — But Not GMPs

  • Post author:Sam
  • Post published:August 4, 2017
  • Post category:The GMP Letter

The FDA finalized its list of 1,003 class II medical devices low-risk enough to be exempt from 510(k) requirements, but stressed that all devices, exempt or otherwise, are subject to…

Continue ReadingFDA Exempts 1,003 Class II Devices From 510(k) Regs — But Not GMPs

National Biological Draws Warning for Nonconformance, Complaints

  • Post author:Sam
  • Post published:August 4, 2017
  • Post category:The GMP Letter

The FDA warned National Biological Corp. for failure to thoroughly investigate complaints and improper handling of out-of-spec products. Source: The GMP Letter

Continue ReadingNational Biological Draws Warning for Nonconformance, Complaints

Whitehall Manufacturing Draws FDA Warning for Therapy Devices

  • Post author:Sam
  • Post published:August 4, 2017
  • Post category:The GMP Letter

Whitehall Manufacturing received a warning letter for multiple violations concerning its whirlpool immersion hydrotherapy and dry heat therapy devices. Source: The GMP Letter

Continue ReadingWhitehall Manufacturing Draws FDA Warning for Therapy Devices

FDA Launches Device Software Pre-certification Pilot

  • Post author:Sam
  • Post published:August 4, 2017
  • Post category:The GMP Letter

The FDA’s new pilot program for pre-certifying software for digital medical devices is up and running and companies can now apply to take part in the program. The goal of…

Continue ReadingFDA Launches Device Software Pre-certification Pilot

Malaysia Issues New Mandatory Device Reporting Requirements

  • Post author:Sam
  • Post published:July 10, 2017
  • Post category:The GMP Letter

Companies will need to report within 48 hours from discovery if a medical device sold in Malaysia presents a serious threat to the public health according to new requirements released…

Continue ReadingMalaysia Issues New Mandatory Device Reporting Requirements

Cardiac Devices Pose Cybersecurity Challenges, Study Finds

  • Post author:Sam
  • Post published:July 10, 2017
  • Post category:The GMP Letter

A new study of the four biggest makers of pacemaker systems found thousands of software vulnerabilities, highlighting an industry-wide problem with software security updates. Source: The GMP Letter

Continue ReadingCardiac Devices Pose Cybersecurity Challenges, Study Finds

Australian Parliament Passes New Device Reforms

  • Post author:Sam
  • Post published:July 10, 2017
  • Post category:The GMP Letter

Both houses of Australia’s Parliament passed a new law to amend the Therapeutic Goods Act 1989 to enable certain variations that do not impact quality, safety or efficacy to be…

Continue ReadingAustralian Parliament Passes New Device Reforms

483 Roundup: FDA Cites Firms Over Complaint Handling, Other Deficiencies

  • Post author:Sam
  • Post published:July 10, 2017
  • Post category:The GMP Letter

The FDA cited device manufacturer US Vascular for a wide range of deficiencies, including inadequate procedures for handling complaints. Source: The GMP Letter

Continue Reading483 Roundup: FDA Cites Firms Over Complaint Handling, Other Deficiencies
  • Go to the previous page
  • 1
  • …
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • …
  • 44
  • Go to the next page

Stay Connected

Keep up with the latest news & insights.

Contact Us

Phone:
+1 858-605-5882
Fax:
+1 858-605-5916
Email:
info@biolegacyresearch.com
Mail:

6042 Cornerstone Court W

Suite E

San Diego, CA 92121

Social:
© 2025 BioLegacy Research. All rights reserved.